PATENT CLAIM ANALYSIS

Application Number: 15908218
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["424", "133100"]

Abstract:
Anti-CD122 and/or γc antibodies and fragments thereof are disclosed. Also disclosed are compositions comprising such antibodies and fragments, and uses and methods using the same.

Claim (Index 1):
An antibody or antigen binding fragment, optionally isolated, which is capable of binding to CD122 and common \u03b3 chain (\u03b3c), wherein the antibody or antigen binding fragment is an IL-2 receptor agonist, and wherein the antibody or antigen-binding fragment comprises:\n (a) an antigen-binding fragment which binds to CD122, comprising:\n (i) a light chain variable region comprising the following CDRs: \n \n LC-CDR1: (SEQ ID NO: 2) TGTSSDIGHYDFVS   LC-CDR2: (SEQ ID NO: 3) DINNRPS   LC-CDR3: (SEQ ID NO: 4) SAYTSSDTLV; \u2003and\n (ii) a heavy chain variable region comprising the following CDRs: \n HC-CDR1: (SEQ ID NO: 36) NYYMH   HC-CDR2: (SEQ ID NO: 37) AIMPSRGGTSYPQKFQG   HC-CDR3: (SEQ ID NO: 38) GEYYYDSSGYYY; \u2003and (b) an antigen-binding fragment which binds to common \u03b3 chain.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 88.0
- Lexical Diversity: 1.4
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15229336', '15750425', '15495048', '15521514', '15521685']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7962380238620174
- 35 USC 102 Novelty (BERT): 0.7388006631629823
- Combined Prediction Score: 0.790494287792114
- Mean Citation Score: 671.658462
- Max Citation Score: 975.4457
- Similarity Product: 808.2176096635461

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test